Homepage — Immunology

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© © University of Oxford Images / John Cairns Photography

Oxford and GSK launch £50m programme to advance cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Read more

Launch of 'To Immunity and Beyond' podcast series

Read more

Pancreatic cancer immune map provides clues for precision treatment targeting

Study shows why there are differences in prognosis between different pancreatic tumours and identifies potential avenues for improved treatment approaches.

Read more

Latest News

Podcast. CellTypeAI: Automated cell identification for scRNA-seq using local generative-AI

2 July 2026

The image depicts CAR T cells killing malignant bone marrow cells that are expressing mutant CALR, illustrated as a red ‘flag’ on the cell surface.

New personalised therapy targets chronic blood cancer

2 July 2026

Foods rich in spermadine include lentils, chickpeas, cheese and broccoli

Natural compound may help boost vaccine responses in older adults

23 June 2026

Scientists in the Department of Paediatrics discover antibody combinations that block over 90% of malaria parasite growth

12 June 2026

Interleukin 10 (IL-10) cytokine protein - looks like a red ribbon

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

11 June 2026

A cancer cell is being targeted by immune T cells

Researchers uncover hidden mechanism behind a major cancer therapy target

9 June 2026

See all news

Upcoming Talks

Connect@CHG Genomics Data Forum

Connect@CHG Genomics Data Forum: Assessing Illumina Spatial Technology using kidney biopsies and other samples

Tuesday, 14 July 2026, 10am to 10.30am

Establishing the epigenome in early mammalian development

Tuesday, 14 July 2026, 2pm to 3pm

Lunchtime Lab Talks: Lucassen Group & CPM

Wednesday, 15 July 2026, 12.30pm to 1.30pm

Prof Beth Psaila - Exploring the MEGAverse - new insights into megakaryocytes and platelets, and their roles in cancer

Wednesday, 15 July 2026, 12.30pm to 1.30pm

Molecular Measurement of Immune Responses

Thursday, 16 July 2026, 11am to 12pm

3’ RNA Uridylation: Biological Insights and Targeted Inhibition as a Cancer Therapy

Thursday, 16 July 2026, 3pm to 4pm

Genetic and Epigenetic Regulation of Synovial Fibroblasts in Rheumatoid Arthritis

Monday, 20 July 2026, 12pm to 1pm

Latest publications

The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization.

Heirene L. et al, (2026), MAbs, 18

DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.

Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15

Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.

van Niekerk L. et al, (2026), MAbs, 18

Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.

Schulz A. et al, (2026), MAbs, 18